Adding Interventional DED Treatment to Your Practice

Interventional treatment for DED before refractive surgery biometry allows practices to offer options like advanced-technology intraocular lenses to more patients.

By
Neel R. Desai, MD
January 1, 2026
14 min

Ophthalmology Management

1

Interventional treatments for dry eye disease (DED) enhance patient care and reduce staff workload in ophthalmology practices.
2

Adopting an interventional approach allows for team-based care, improving efficiency and patient access to effective treatments.
3

Lacrimal occlusion with hyaluronic acid gel is a first-line therapy for DED, providing immediate symptomatic relief and improving compliance.
4

Thermal-activated restorative gland expression therapy (TARGET) effectively treats meibomian gland dysfunction and evaporative disease.
5

Interventional treatments like TARGET and Lacrifill are supported by data showing better outcomes compared to traditional therapies.

Adding Interventional DED Treatment to Your Practice

1

2

3

4

5

Original Source(s)

Adding Interventional DED Treatment to Your Practice

Related Content

Assessment of the aggregate index of systemic inflammation in dyslipidemia with dry eye disease: a retrospective case-control

Wogonoside alleviates hyperosmotic stress-induced inflammation and apoptosis in human corneal epithelial cells via PI3K/AKT signaling

Ocular Surface Optimization: The Best First Step in Modern Cataract Surgery